Optimizing real-world evidence studies for regulatory decision-making and impact assessment in pharmacovigilance

IF 3 3区医学 Q2 PHARMACOLOGY & PHARMACY British journal of clinical pharmacology Pub Date : 2025-01-17 DOI:10.1111/bcp.16393

Ignatios Ioakeim-Skoufa, Kerry Atkins, Miguel Ángel Hernández-Rodríguez

引用次数: 0

Abstract

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

优化药物警戒中监管决策和影响评估的真实世界证据研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

British journal of clinical pharmacology 医学-药学

CiteScore

6.30

自引率

8.80%

发文量

419

审稿时长

1 months

期刊介绍： Published on behalf of the British Pharmacological Society, the British Journal of Clinical Pharmacology features papers and reports on all aspects of drug action in humans: review articles, mini review articles, original papers, commentaries, editorials and letters. The Journal enjoys a wide readership, bridging the gap between the medical profession, clinical research and the pharmaceutical industry. It also publishes research on new methods, new drugs and new approaches to treatment. The Journal is recognised as one of the leading publications in its field. It is online only, publishes open access research through its OnlineOpen programme and is published monthly.

期刊最新文献

Completion vs. early discontinuation of chemotherapy and the impact on 5-year all-cause mortality in women treated for early-stage breast cancer from 2015 to 2020: A cohort study using a target trial emulation approach. Why do healthy volunteers participate in clinical trials? Pharmacokinetics and pharmacodynamics of intravenous and oral (S)-ketamine: Investigating metabolite contribution to subjective effects. Pharmacokinetic drug-drug interactions with flucloxacillin and other isoxazolyl penicillins: A systematic literature review and practical guide. Factors associated with intentional non-adherence to endocrine treatment among early breast cancer survivors: A multicenter cross-sectional study.